Dermatology

Latest News

Dupilumab and Other Monoclonals Rank Highly for Moderate-to-Severe Atopic Dermatitis, Network Meta-Analysis Shows / Image credit: ©aamylya/AdobeStock
Dupilumab and Other Monoclonals Rank Highly for Moderate-to-Severe Atopic Dermatitis, Network Meta-Analysis Shows

December 9th 2025

A new meta-analysis reveals monoclonal antibodies, including dupilumab, outperform placebo in treating moderate-to-severe atopic dermatitis.

Early Biologic Therapy for Hidradenitis Suppurativa Supported by Majority of Specialists, Survey Shows / image credit: ©syahrir/AdobeStock
Early Biologic Therapy for Hidradenitis Suppurativa Supported by Majority of Specialists, Survey Shows

December 8th 2025

Topical Roflumilast 0.3% Demonstrates Significant Efficacy Across Psoriasis Severity Measures in Updated Meta-Analysis / Image credit: ©molekuul.be/AdobeStock
Topical Roflumilast 0.3% Demonstrates Significant Efficacy Across Psoriasis Severity Measures in Updated Meta-Analysis

December 8th 2025

T6 Degrader KT-621 Shows Biologic-Like Activity in Early Atopic Dermatitis Trial / image credit ©Designua/stock.adobe.com
Kymera's Oral STAT6 Degrader KT-621 Shows Biologic-Like Activity in Early Atopic Dermatitis Trial

December 8th 2025

Treating Body and Mind in Atopic Dermatitis: Priorities for Primary Care / image credit ©fizkes/stock.adobe.com
Treating Body and Mind in Atopic Dermatitis: Priorities for Primary Care

December 1st 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.